James K. Ireland

FDA investigator

Appears on 10 documents from 2016 to 2019, mostly at sites in Minnesota. Most often cites control of microbiological contamination (21 CFR 211.113).

10
Documents on file
4.6
Observations per 483
2016
First seen
2019
Most recent

What they cite most

From 46 observations

Activity by year

2016: 1, 2017: 1, 2018: 5, 2019: 3

Where

Minnesota 6 · Wisconsin 2 · Illinois 1 · Michigan 1

Is James K. Ireland coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Techni Med, Inc. dba The CompounderOct 10, 2019 · Aurora, Illinois
483 Radix Laboratories IncJul 25, 2019 · Eau Claire, Wisconsin
483 LTS Therapy Systems, LLCJan 31, 2019 · West St. Paul, Minnesota
483 EPIEN Medical, Inc.Dec 6, 2018 · St. Paul, Minnesota
483 SV Labs Prescott CorporationSep 28, 2018 · Prescott, Wisconsin
483 Pharmacia & Upjohn Company LLCSep 21, 2018 · Kalamazoo, Michigan
483 Mayo Clinic PharmacyAug 15, 2018 · Rochester, Minnesota

About this profile

What does James K. Ireland inspect?

James K. Ireland appears on 10 documents on file covering 10 sites, mostly in Minnesota.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.22 and 21 CFR 211.165.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for James K. Ireland is dated Oct 10, 2019.